“What they’ve done is taken papers that have already received attention within the scientific community, and then they’ve set out to try and determine whether or not that work could be independently reproduced.” (From 2021)
Science obviously works, broadly. So why is it so hard to replicate an experiment? “One answer is: Science is hard,” Errington says. “That’s why we fund research and invest billions of dollars just to make sure cancer research can have an impact on people’s lives. Which it does.”
The point of less-than-great outcomes like the cancer project’s is to distinguish between what’s good for science internally and what’s good for science when it reaches civilians. “There are two orthogonal concepts here. One is transparency, and one is validity,” says Shirley Wang, an epidemiologist at Brigham and Women’s Hospital.
The point, then, isn’t to critique specific results. It’s to make science more transparent, which should in turn make the results more replicable, more understandable, maybe even more likely to translate to the clinic. Right now, academic researchers don’t have an incentive to publish work that other researchers can replicate. The incentive is just to publish.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Colonoscopies save lives. Doctors push back against European study that casts doubtColon cancer specialists worry that results of a study published this week in the New England Journal of Medicine could be misconstrued, and keep patients from getting lifesaving cancer screening.
続きを読む »
Uncertain role for colonoscopy screening⭐ Research Highlight: Despite a reduction in colorectal cancer incidence, a large, randomized study shows no impact of colonoscopy screening on cancer-related deaths (though screening uptake was low) NEJM
続きを読む »
Trending Clinical Topic: Folic AcidNew research showing folic acid's benefit in liver disease, gastric conditions, and suicidality was joined by a study on potential for cancer development, leading to the top trending topic this week.
続きを読む »
Lifetime of Stress Tied to Big Rise in Cancer Risk - MedicineNet Health NewsOver time, men and women under chronic stress face a significantly higher risk that they will die as a result of cancer, a new study warns.
続きを読む »
Moderna and Merck Will Jointly Develop a Cancer Vaccine for High-Risk Melanoma PatientsModerna's messenger RNA vaccine is being studied in combination with Merck's Keytruda to treat patients with high-risk melanoma, the deadliest form of skin cancer, in a phase two trial.
続きを読む »
Patients With Cancer Are at a Lower Risk of DementiaPatients with cancer had a lower risk of all-cause dementia and its subtypes such as Alzheimer's disease and vascular dementia, study finds.
続きを読む »